Your contact person
Manager PR & Communications Jan Phillip Denkers
Large-scale project iSenseDNA launched
Understanding how a specific molecule behaves during complex biological processes is a challenge facing biomedical research, despite major biotechnological progress made in recent years. A ...
Read more …
Indivumed Joins KHR Biotech
Indivumed GmbH (“Indivumed”) CEO Dr. Hartmut Juhl and University Medical Center Mainz Professor Krishnaraj Rajalingam today announced Indivumed will be joining the newly formed KHR ...
Read more …